Home » Stocks » MDVL

MedAvail, Inc (MDVL)

Stock Price: $11.50 USD -0.50 (-4.17%)
Updated May 12, 2021 4:00 PM EDT - Market closed
Market Cap 373.77M
Revenue (ttm) 13.97M
Net Income (ttm) -26.81M
Shares Out 5.72M
EPS (ttm) -4.69
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 12
Last Price $11.50
Previous Close $12.00
Change ($) -0.50
Change (%) -4.17%
Day's Open 11.66
Day's Range 11.18 - 11.86
Day's Volume 29,520
52-Week Range 0.84 - 20.79

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the first...

2 weeks ago - Business Wire

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced that a health system in North Texas ha...

4 weeks ago - Business Wire

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today reported financial results for the three months and full...

1 month ago - Business Wire

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the fourt...

1 month ago - Business Wire

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced that TMCOne has continued to expand it...

2 months ago - Business Wire

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company, today announced that the company will be participating ...

2 months ago - Business Wire

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced preliminary financial and operational results ...

2 months ago - Business Wire

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail, Inc. (“MedAvail”), a technology-enabled retail pharmacy company driving best in class medication adherence by embedding its pharmacy services d...

3 months ago - Business Wire

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company driving best in class medication adherence by embedding ...

3 months ago - Business Wire

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company driving best in class medication adherence by embedding...

4 months ago - Business Wire

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company driving best in class medication adherence by embedding ...

4 months ago - Business Wire

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (“MedAvail”), a leading technology-enabled pharmacy organization that embeds automated pharmacy services directly into clinics an...

5 months ago - Business Wire

MISSISSAUGA, Ontario & CEDAR KNOLLS, N.J.--(BUSINESS WIRE)--MedAvail, Inc. (“MedAvail”), a leading technology-enabled pharmacy organization that embeds pharmacy services directly into clinics and other ...

Other stocks mentioned: MYOS
5 months ago - Business Wire

CEDAR KNOLLS, N.J., Nov. 12, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS) As previously announced, on June 30, 2020, MYOS RENS Technology, Inc., a Nevada corpo...

Other stocks mentioned: MYOS
6 months ago - PRNewsWire

CEDAR KNOLLS, N.J., Nov. 6, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive ...

Other stocks mentioned: MYOS
6 months ago - PRNewsWire

NEW YORK, July 7, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of MYOS RENS Technology Inc. ("MYOS" or the...

Other stocks mentioned: MYOS
10 months ago - PRNewsWire

CEDAR KNOLLS, N.J., July 7, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a biotherapeutics and bionutrition company and the owner of Fortetropin®, a proprieta...

Other stocks mentioned: MYOS
10 months ago - PRNewsWire

NEW YORK, July 2, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger between MYOS RENS Technology Inc. (NASDAQ: MYOS) and MedAvail, Inc. is fai...

Other stocks mentioned: MYOS
10 months ago - PRNewsWire

New York, New York--(Newsfile Corp. - July 2, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased MYOS RENS Technology Inc. (NASDAQ: MYOS) ...

Other stocks mentioned: MYOS
10 months ago - Newsfile Corp

Shares of nutrition company MYOS Corporation (NASDAQ: MYOS) were more than doubling Wednesday.

Other stocks mentioned: MYOS
10 months ago - Benzinga

CEDAR KNOLLS, N.J. and MISSISSAUGA, Ontario, June 30, 2020 /PRNewswire/ -- MYOS RENS Technology, Inc. ("MYOS") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary ...

Other stocks mentioned: MYOS
10 months ago - PRNewsWire

CEDAR KNOLLS, N.J., May 14, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition that helps b...

Other stocks mentioned: MYOS
11 months ago - PRNewsWire

MYOS RENS Technology's (MYOS) CEO Joseph Mannello on Q1 2020 Results - Earnings Call Transcript

Other stocks mentioned: MYOS
1 year ago - Seeking Alpha

MYOS RENS Technology Inc (MYOS) CEO Joseph Mannello on Q4 2019 Results - Earnings Call Transcript

Other stocks mentioned: MYOS
1 year ago - Seeking Alpha

MYOS RENS Technology Inc (MYOS) CEO Joseph Mannello on Q3 2019 Results - Earnings Call Transcript

Other stocks mentioned: MYOS
1 year ago - Seeking Alpha

MYOS RENS Technology Inc. (MYOS) CEO Joseph Mannello on Q1 2019 Results - Earnings Call Transcript

Other stocks mentioned: MYOS
2 years ago - Seeking Alpha

MYOS RENS Technology Inc. (MYOS) CEO Joseph Mannello on Q4 2018 Results - Earnings Call Transcript

Other stocks mentioned: MYOS
2 years ago - Seeking Alpha

About MDVL

MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery. MedAvail Holdings, Inc. is based in Mississau... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
CEO
Joseph Mannello
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
MDVL
Full Company Profile

Financial Performance

In 2020, MedAvail's revenue was $13.97 million, an increase of 270.41% compared to the previous year's $3.77 million. Losses were -$26.81 million, 24.5% more than in 2019.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for MedAvail is 20.00, which is an increase of 73.91% from the latest price.

Price Target
$20.00
(73.91% upside)